Vectura Fertin Pharma, Inc., a Subsidiary of Philip Morris International, Announces Agreement for Sale of Vectura Group to Molex

Contributed by: Business Wire

Tags

Retail

Health

Medical Devices

Manufacturing

Tobacco

Other Manufacturing

Pharmaceutical

Vectura Fertin Pharma, Inc.

More Like This

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation

Phillips Medisize Expands Its Inhalation Drug Delivery Capabilities

Phillips Medisize Announces Scientific Presentations and Engagements at Respiratory Drug Delivery Conference, Highlighting Its Expanded Inhalation Drug Delivery Capabilities

PMI and BAT Announce Global Patent Settlement

Philip Morris International Demonstrates Clear Progress Toward Its Purpose as It Releases 2023 Integrated Report

Production of ZYN oral nicotine pouches at the Swedish Match Owensboro, Ky., facility. (Photo: Business Wire)

Philip Morris International U.S. Affiliate to Create 500 Jobs Investing $600 Million in Aurora, Colo., Manufacturing Facility

Philip Morris International Announces Senior Global Communications Leadership Changes

Philip Morris International Releases Integrated Report Detailing Progress Towards Its Smoke-Free Vision